Excessive intrapancreatic fat deposition (IPFD) leading to fatty change of the pancreas (FP) was prevalent in almost 18% of participants in a large population-based cohort, and both IPFD and FP were ...

Exocrine pancreatic insufficiency (EPI) is most commonly caused by conditions affecting the pancreas, such as chronic pancreatitis, celiac disease, diabetes, and cystic fibrosis. However, people ...

In the largest study of its kind, researchers at Vanderbilt University Medical Center have identified unexpected alterations in the exocrine tissues of the pancreas that occur in the two major forms ...

Rising EPI diagnoses, longer cystic fibrosis survival and undertreatment are expanding PERT demand, while porcine shortages spur recombinant enzymes, generics and digital adherence tools.Dublin, Aug.

Over one third of patients with acute pancreatitis develop exocrine pancreatic insufficiency (EPI) at 12 months, with the key predictors being idiopathic etiology, moderately severe or severe disease, ...

Pancreatic enzyme replacement therapy can help you effectively manage the symptoms of exocrine pancreatic insufficiency. You can also do your part to make sure your treatment is even more successful.

Please provide your email address to receive an email when new articles are posted on . Exocrine pancreatic insufficiency should be suspected among patients with high-risk clinical conditions, such as ...

(A) Representative H&E staining image of a mouse pancreas. The black arrow denotes the acinar cells and the white arrow denotes the islet. (B) Representative image of electron microscopy analysis of ...

Thinking about the future, it’s inevitable that other cancer drugs like Rasonque will launch at similar or even higher prices ...

The pancreas often only becomes noticeable when something is wrong. The signs can be surprisingly varied: changes after ...